Plain-English translation of NCT06307314 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at a protein in your blood called SAA1 to see if it can predict whether you'll develop mouth sores during radiation therapy for head and neck cancer. Researchers have found that SAA1 levels change after radiation exposure, and they want to understand if measuring this protein early on could help doctors predict and prevent painful mouth sores before they happen.
Almost all patients who receive radiation for head and neck cancer develop painful mouth sores that can affect their quality of life and ability to continue treatment. This study exists to find a way to predict early which patients are at highest risk, so doctors can take steps to prevent or reduce this side effect.
You likely qualify if…
You likely don't qualify if…
You will have blood samples taken at various points during and after your radiation therapy so researchers can measure your SAA1 protein levels. This is an observational study, meaning doctors are watching and collecting information rather than giving you a new medication — you'll continue your standard cancer treatment as planned. The study involves about 300 participants being followed at multiple hospitals to gather enough information to see if SAA1 levels can reliably predict mouth sores.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China